Quick Answer
DEXCOM INC reported Operating Income of $911.80 million for fiscal year 2025.
DEXCOM INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $911.80M | +52.0% |
| 2024 | $600.00M | +0.4% |
| 2023 | $597.70M | +52.8% |
| 2022 | $391.20M | +47.2% |
| 2021 | $265.80M | -11.3% |
| 2020 | $299.50M | +110.5% |
| 2019 | $142.30M | +176.4% |
| 2018 | -$186.30M | -338.4% |
| 2017 | -$42.50M | +33.5% |
| 2016 | -$63.90M | -11.9% |
| 2015 | -$57.10M | -165.6% |
| 2014 | -$21.50M | +25.6% |
| 2013 | -$28.90M | +48.1% |
| 2012 | -$55.70M | -24.3% |
| 2011 | -$44.80M | +1.1% |
| 2010 | -$45.30M | +1.2% |
| 2009 | -$45.83M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $242.50M | +59.5% | +14.1% |
| June 30, 2025 | $212.60M | +34.6% | +59.0% |
| March 31, 2025 | $133.70M | +32.2% | -12.0% |
| September 30, 2024 | $152.00M | -26.0% | -3.8% |
| June 30, 2024 | $158.00M | +23.3% | +56.3% |
| March 31, 2024 | $101.10M | +114.2% | -50.8% |
| September 30, 2023 | $205.50M | +39.3% | +60.4% |
| June 30, 2023 | $128.10M | +66.4% | +171.4% |
- DEXCOM INC showed an increase of +52.0% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, DEXCOM INC’s operating income has grown by 2089.4% (from -$45.83 million to $911.80 million).
- The most recent figure is from DEXCOM INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: